ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P ASX 200
8,198.10
-0.58%
S&P ASX All Technology
3,744.30
-0.79%
Brent Oil
70.485
-1.28%
US Dollar vs AUD
1.60676
-0.13%
Bitcoin
83,824.32
-2.63%
Pepperstone
Advertisement
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Brazil
  5. BOV

  6. Ventas Inc (V1TA34) Share Price

Ventas Inc

Ventas Inc (V1TA34)

BOV
202.60
13.96
(7.40%)
Closed 04 March 7:55AM
Delayed by 15 minutes

Professional-Grade Tools, for Individual Investors.

Premium

Key stats and details

Current Price
202.60
Bid
202.80
Offer
204.20
Volume
30
202.60 Day's Range 202.60
105.80 52 Week Range 202.60
Market Cap
84.961B
Previous Close
188.64
Open
202.60
Last Trade
30
@
202.6
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
13
Shares Outstanding
419,355,000
Dividend Yield
1.88%
PE Ratio
363.62
Earnings Per Share (EPS)
0.19
Revenue
4.9B
Net Profit
81.15M

About Ventas Inc

Sector
Real Estate Investment Trust
Industry
Real Estate Investment Trust
Website
www.ventasreit.com
Headquarters
Wilmington, Delaware, USA
Founded
-
Ventas Inc is listed in the Real Estate Investment Trust sector of the Brazil Bovespa Exchange with ticker V1TA34. The last closing price for Ventas was R$188.64. Over the last year, Ventas shares have traded in a share price range of R$ 105.80 to R$ 202.60.

Ventas currently has 419,355,000 shares in issue. The market capitalisation of Ventas is R$79.11 billion. Ventas has a price to earnings ratio (PE ratio) of 363.62.

Ask ADVFN Intelligence (AI)

V1TA34 Latest News

More News
No news to show yet.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1000202.6000DR
422.612.5555555556180202.61804185.43846154DR
1226.1114.7940393223176.49202.6176.4913179.84584615DR
2624.7213.8970092197177.88202.6168.4263180.94028399DR
5294.887.9406307978107.8202.6105.8145138.48195303DR
15660.4142.48540685142.19202.694.42205127.4315086DR
260140.86228.15030774261.74202.652.51213128.47535986DR

V1TA34 - Frequently Asked Questions (FAQ)

What is the current Ventas share price?
The current share price of Ventas is R$ 202.60
How many Ventas shares are in issue?
Ventas has 419,355,000 shares in issue
What is the market cap of Ventas?
The market capitalisation of Ventas is BRL 79.11B
What is the 1 year trading range for Ventas share price?
Ventas has traded in the range of R$ 105.80 to R$ 202.60 during the past year
What is the PE ratio of Ventas?
The price to earnings ratio of Ventas is 363.62
What is the cash to sales ratio of Ventas?
The cash to sales ratio of Ventas is 6.03
What is the reporting currency for Ventas?
Ventas reports financial results in USD
What is the latest annual turnover for Ventas?
The latest annual turnover of Ventas is USD 4.9B
What is the latest annual profit for Ventas?
The latest annual profit of Ventas is USD 81.15M
What is the registered address of Ventas?
The registered address for Ventas is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
What is the Ventas website address?
The website address for Ventas is www.ventasreit.com
Which industry sector does Ventas operate in?
Ventas operates in the REAL ESTATE INVESTMENT TRUST sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
PDGR3PDG Realty S.A. Empreendimentos E Participacoes
R$ 0.71
(7,000.00%)
3.48M
PLAS3Plascar Participacoes Industriais Sa
R$ 7.08
(15.50%)
600
PEAB4Cia Participacoes Alianca Bahia
R$ 51.00
(13.33%)
1,000
ONCO3Oncoclinicas Brasil Servicos Medico
R$ 5.62
(11.07%)
21.17M
AMAR3Lojas Marisa S.A.
R$ 1.35
(7.14%)
721.1k
DASA11Diagnosticos da America S.A
R$ 0.24
(-20.00%)
27.2k
AZTE3Azevedo & Travassos Energia Sa
R$ 1.39
(-10.32%)
16.42M
MRFG3Marfrig Global Foods S.A
R$ 13.63
(-10.15%)
12.43M
PGMN11Empreendimentos Pague Menos S.A.
R$ 0.18
(-10.00%)
8.6k
RCSL3Recrusul Sa
R$ 3.12
(-7.14%)
836.2k
HAPV3Hapvida Participacoes Investimento SA
R$ 2.11
(-0.47%)
703.39M
CSAN3Cosan SA
R$ 7.09
(-2.07%)
226.15M
COGN3CognaEducacao SA
R$ 1.52
(-1.94%)
104.97M
CSNA3Cia Siderurgica Nacional
R$ 8.52
(-1.73%)
91.03M
BBDC4Bco Bradesco Sa
R$ 11.24
(-2.01%)
84.39M

Discussion

View Full Feed
glenn1919 glenn1919 57 seconds ago
TSLZ.......................SYTA..............................https://stockcharts.com/h-sc/ui?s=TSLZ&p=W&yr=1&mn=3&dy=0&id=p96837884856
SYTA TSLZ
Chiron Chiron 1 minute ago
With this float it should be .003 +
BLLB
hedge_fun hedge_fun 1 minute ago
Their focus is the 10 year. It’s going……..

as planned.

And they say, don’t fight the fed.
SMCI
Omar8 Omar8 2 minutes ago
DP,




From a post by ANT....."Jon Jon. 1st I do not have an attorney handling this I'm handling it myself. An attorney would have cost 30-40,000 already. I am familiar with the Faro's attorney a very large multi state firm where junior attorneys cost 4-500 and se
NNLX
nanobuyer nanobuyer 5 minutes ago
Yesterday and today, my attempts to access groen-tech.com result in Norton flagging the site as a potential trojan-horse. While that's not necessarily the case, it does indicate another change to the website—by whom and why? Just curious.
glenn1919 glenn1919 5 minutes ago
tslz................................................................................................p/m
TSLZ
Stino2 Stino2 6 minutes ago
To bad for the board of company that the stock is sooooo low 🤮
TNXP
gedi8 gedi8 7 minutes ago
We will see my friend. His first month in office has really hurt the market. I hope you are right

No need for personal attacks. I states an opinion. If you disagree that’s okay.
NXPL
WooptdooU WooptdooU 8 minutes ago
Why don't these GRIFTERS use their OWN money and buy at the market.... they are NOT AFRAID of the helplessly hopeful pennylongs.
LWLG
louieforpar louieforpar 8 minutes ago
Less than four one way or another. 


glenn1919 glenn1919 9 minutes ago
INLF....................................................................................p/m
INLF
uranium-pinto-beans uranium-pinto-beans 10 minutes ago
OKTA
Okta upgraded to Buy from Neutral at DA Davidson
DA Davidson analyst Rudy Kessinger upgraded Okta to Buy from Neutral with a price target of $125, up from $90. The company reported "very strong" Q4 results and meaningfully raised its fiscal 2026 guidance, the analyst tells inve
OKTA
WooptdooU WooptdooU 11 minutes ago
These scummy insiders have done NOTHING but TAKE...they must believe the helplessly hopeful pennylongs are harmless to them.
LWLG
uranium-pinto-beans uranium-pinto-beans 12 minutes ago
mmmm


https://www.bloomberg.com/news/articles/2025-03-03/citi-copy-paste-error-almost-sent-6-billion-to-wealth-account
uranium-pinto-beans uranium-pinto-beans 13 minutes ago
OKTA
Okta price target raised to $100 from $94 at Canaccord
Canaccord raised the firm's price target on Okta to $100 from $94 and keeps a Hold rating on the shares. The firm said they reported resoundingly positive Q4 results ahead of both the firm's and consensus expectations with
OKTA
uranium-pinto-beans uranium-pinto-beans 13 minutes ago
MCHP
Microchip cyclical bottom may be forming, says JPMorgan
Jefedejefes Jefedejefes 14 minutes ago
listening to your favorite song... over, and over, and over https://www.youtube.com/watch?v=BfnjX88Va4Y
EDXC
docj docj 18 minutes ago
"One example: the current CEO of Cytodyn was CMO under Nader Pourhassan the Frauder, and was fine with all his actions."

That is a false statement. It is a matter of public record how Dr JL felt about Nader. Stop trying to make it look like he was complicit with Nader's actions. It lo
CYDY
meixatech meixatech 19 minutes ago
"Oral bioavailability" is one of the most important properties in drug design and development. A high oral bioavailability reduces the amount of an administered drug necessary to achieve a desired pharmacological effect and therefore could reduce the risk of side-effects and toxicity.
RSPI
trader53 trader53 19 minutes ago
Nixon's Restaurants have not gone belly up


https://investorshub.advfn.com/uicon/155361.png?cb=636360310707230000
______________________________________________________________________


Nixon Restaurant Group Inc
is operated in Colorado ,
gp22 gp22 20 minutes ago
$ESLA @ $1.05....Given $16 one year target last week by highly regarded bio/pharma ETF...Hit $1.80s 2 weeks ago and backed off..$ESLA a repeat of Immuno $IOVA & $SMMT monster moves
Link: 9/29/24
https://finance.yahoo.com/news/estrella-immunopharma-achieves-complete-response-160000432.h
ESLA IOVA SMMT
WooptdooU WooptdooU 21 minutes ago
Grifter siraj...eom
LWLG

Your Recent History

BOV
V1TA34
Ventas
BIT
UIB499
Unicredit Bank
LSE
85LI
Higher Ed.1 A2s
BIT
UB26G4
UniCredit Bank
LSE
BEZ
Beazley
NEO
FCLS
Fidelity Canadian Long S...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads